超声引导下穿刺活检对乳腺病变诊断价值的研究进展

Abstract
Figure/Table
References (32)
Related Citation (15)

Download: PDF (0 KB) HTML (41 KB)
Export: BibTeX | EndNote (RIS)

Abstract

The decision-making for the treatment of breast lesions is affected by the pathological results,but the underestimation of puncture pathology occurs frequently.In order to improve the detection rate of lesions and the pathological coincidence rate,it is necessary to evaluate types of lesions which are easily missed or underestimated.This paper analyzed the underestimation rates of different types of breast lesions by ultrasound-guided needle biopsy in recent years,possible causes of underestimation,and high-risk factors for underestimation.Auxiliary methods could be used to improve the detection rate and evaluation accuracy of ultrasound-guided needle biopsy in the diagnosis of non-mass and small-volume breast lesions.The evaluation accuracies of intraductal papillary lesions and invasive breast cancer were relatively high.However,due to the tumor heterogeneity and tumor center necrosis,it was necessary to conduct multi-point selection of cancer materials for invasive breast cancer to improve the coincidence rate of immunohistochemical conclusions.The evaluation accuracies of atypical hyperplasia,lobular carcinoma in situ,and ductal carcinoma in situ were not ideal,and follow-up close monitoring or surgical treatment was required.For breast lesions that might be malignant,a puncture sheath should be used during puncture to avoid the occurrence of puncture needle implant transfer,or radiotherapy should be used in subsequent treatment to reduce the chance of implant transfer.In summary,ultrasound-guided hollow-core needle biopsy is currently the preferred method for diagnosing breast lesions.Nuclear magnetic-guided needle biopsy and vacuum-assisted biopsy can become new choices for material selection.

Key words： Ultrasound-guided needle biopsy Core needle biopsy Breast lesions Diagnostic value

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Ao-xue
	JIA Hong-yan

Cite this article:

ZHANG Ao-xue,JIA Hong-yan. Research progress of the value of ultrasound-guided needle biopsy in diagnosis of breast lesions[J]. 中国当代医药, 2021, 28(23): 36-39转44.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I23/36

[1]	Dinas K，Pratilas GC，Nasioutziki M，et al.Clinical significance of fine needle aspiration in managing patients with breast lesions[J].Folia Med（Plovdiv），2018，60（3）：364-372.
[2]	Lukasiewicz E，Ziemiecka A，Jakubowski W，et al.Fine -needle versus core-needle biopsy-which one to choose in preoperative assessment of focal lesions in the breasts?Literature review[J].J Ultrason，2017，17（71）：267-274.
[3]	Tamaki K，Sasano H，Ishida T，et al.Comparison of core needle biopsy（CNB）and surgical specimens for accurate preoperative evaluation of ER，PgR and HER2 status of breast cancer patients[J].Cancer Sci，2010，101（9）：2074-2079.
[4]	Xu P，Wu M，Yang M，et al.Evaluation of internal and shell stiffness in the differential diagnosis of breast non-mass lesions by shear wave elastography[J].World J Clin Cases，2020，8（12）：2510-2519.
[5]	Rizzo M，Linebarger J，Lowe MC，et al.Management of papillary breast lesions diagnosed on core-needle biopsy：clinical pathologic and radiologic analysis of 276 cases with surgical follow-up[J].J Am Coll Surg，2012，214（3）：280-287.
[6]	Park SY，Ko SS，Yoon CS，et al.Factors associated with disease upgrading in patients with papillary breast lesion in core-needle biopsy[J].Gland Surg，2020，9（4）：919-924.
[12]	张春，禹雪，张永辉，等.空芯针穿刺活检在乳腺导管内乳头状肿瘤中的诊断价值[J].中国微创外科杂志，2019，19（9）：800-802，816.
[16]	范照青，欧阳涛，李金锋，等.乳腺病变穿刺组织病理学检查非恶性结果的处理[J].中华医学杂志，2008，88（34）：2387-2390.
[21]	张国芬，张虹，辛灵，等.乳腺病灶空芯针穿刺活检与术后病理诊断一致性分析（附1394 例报告）[J].中国实用外科杂志，2014，34（7）：660-662.
[31]	曹威，何英剑，李金锋，等.超声引导下空芯针穿刺活检诊断的乳腺导管原位癌病理学低估的危险因素分析[J].中国癌症杂志，2020，30（3）：217-223.
[7]	Ko D，Kang E，Park SY，et al.The Management Strategy of Benign Solitary Intraductal Papilloma on Breast Core Biopsy[J].Clin Breast Cancer，2017，17（5）：367-372.
[8]	Han SH，Kim M，Chung YR，et al.Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision[J].J Breast Cancer，2018，21（1）：80-86.
[9]	Li X，Weaver O，Desouki MM，et al.Microcalcification is an important factor in the management of breast intraductal papillomas diagnosed on core biopsy[J]Am J Clin Pathol，2012，138（6）：789-795.
[10]	Pareja F，Corben AD，Brennan SB，et al.Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies：Rate of upgrade to carcinoma at excision[J].Cancer，2016，122（18）：2819-2827.
[11]	Grimm LJ，Bookhout CE，Bentley RC，et al.Concordant，non-atypical breast papillomas do not require surgical excision：A 10-year multi-institution study and review of the literature[J].Clin Imaging，2018，51：180-185.
[13]	Sen LQ，Berg WA，Hooley RJ，et al.Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia[J].AJR Am J Roentgenol，2016，207（5）：1132-1145.
[14]	Wazir U，Wazir A，Wells C，et al.Pleomorphic lobular carcinoma in situ：Current evidence and a systemic review[J].Oncol Lett，2016，12（6）：4863-4868.
[15]	Mooney KL，Bassett LW，Apple SK.Upgrade rates of highrisk breast lesions diagnosed on core needle biopsy：a single-institution experience and literature review[J].Mod Pathol，2016，29（12）：1471-1484.
[17]	Chen LY，Hu J，Tsang JYS，et al.Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy[J].Histopathology，2019，75（3）：320-328.
[18]	Morrow M，Schnitt SJ，Norton L.Current management of lesions associated with an increased risk of breast cancer[J].Nat Rev Clin Oncol，2015，12（4）：227-238.
[19]	Sutton T，Farinola M，Johnson N，et al.Atypical ductal hyperplasia：Clinicopathologic factors are not predictive of upgrade after excisional biopsy[J].Am J Surg，2018，217（5）：848-850.
[20]	Mesurolle B，Perez JC，Azzumea F，et al.Atypical ductal hyperplasia diagnosed at sonographically guided core needle biopsy：frequency，final surgical outcome，and factors associated with underestimation[J].AJR Am J Roentgenol，2014，202（6）：1389-1394.
[32]	任重阳，廖宁，张国淳，等.乳腺真空辅助旋切系统活检后乳腺癌患者针道转移的几率[J].南方医科大学学报，2014，34（7）：1016-1019，1024.
[22]	Benyahia Z，Dussault N，Cayol M，et al.Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion[J].Oncotarget，2017，8（9）：15 744-15 762.
[23]	Moelans CB，de Groot JS，Pan X，et al.Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA[J].Mod Pathol，2014，27（6）：869-874.
[24]	Zhu S，Wu J，Huang O，et al.Clinicopathological Features andDiseaseOutcomeinBreastCancerPatientswithHormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample[J].Ann Surg Oncol，2019，26（9）：2779-2786.
[25]	Kombak FE，Sahin H，Mollamemisoglu H，et al.Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer[J].Turk J Med Sci，2017，47（6）：1791-1796.
[26]	You K，Park S，Ryu JM，et al.Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry[J].J Breast Cancer，2017，20（3）：297-303.
[27]	Asogan AB，Hong GS，Arni Prabhakaran SK.Concordance between core needle biopsy and surgical specimen for oestrogen receptor，progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer[J].Singapore Med J，2017，58（3）：145-149.
[28]	Jung I，Kim MJ，Moon HJ，et al.Ultrasonography-guided 14-gauge core biopsy of the breast：results of 7 years of experience[J].Ultrasonography，2018，37（1）：55-62.
[29]	Caswell-Smith P，Wall M.Ductal carcinoma in situ：Is core needle biopsy ever enough?[J].J Med Imag Radiat Oncol，2016，61（1）：29-33.
[30]	Kim J，Han W，Lee JW，et al.Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision[J].Breast，2012，21（5）：641-645.
[33]	Santiago L，Adrada BE，Huang ML，et al.Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast[J].Breast Cancer Res Treat，2017，166（1）：29-39.